| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.06 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.06 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.06 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.06 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.06 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.059 | 0.06 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.089 | 0.07 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.052 | 0.07 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.064 | 0.07 |